Ana Goios, PhD
Medical Writer — HIV & Infectious Disease
PhD geneticist with more than 15 years of academic research, 25+ peer-reviewed publications, and a co-authored HIV systematic review in a leading journal. Ana brings the same scientific rigor she applies to regulatory medical writing to every patient-facing article she produces for SunnyPharma.
The Difference a Geneticist Makes
Most medical content about HIV treatment is written by people who learned the science by reading about it. Ana learned it by doing it — fifteen years inside research laboratories where the molecular techniques used to detect resistance mutations and quantify viral load were the daily tools of her work. When she explains how a single-tablet regimen inhibits reverse transcriptase and integrase, she is drawing on the genetics training that produced her PhD and the bench experience behind 25-plus peer-reviewed papers — not a summary of someone else’s explanation.
That depth changes what readers get. Ana’s articles for SunnyPharma cover the same ground other HIV resources cover — how Biktarvy works, its side-effect profile, the broader medication landscape — but the explanation underneath is grounded in molecular reality, not a surface restatement of the prescribing information.
From the Lab to the Page
Ana earned her BSc in Biology from the Faculty of Sciences at the University of Porto and completed her PhD in Genetics at the same institution. Her doctoral research focused on the dynamics of the mitochondrial genome and the boundary between normal and pathogenic diversity. Her doctoral and post-doctoral work at IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto) produced over 25 peer-reviewed publications in international journals — covering mitochondrial DNA phylogenetics, forensic DNA analysis, nuclear–mitochondrial DNA contamination, and the genetic history of human populations.
She later worked as a genetics technician at an accredited diagnostics laboratory, implementing tests for genetic disorders and writing clinical and technical laboratory reports, then joined a Population Health research group, broadening her expertise in epidemiology and health-data analysis. It was in this period that she co-authored a systematic review in JAIDS on how immunological non-response to antiretroviral therapy is defined across the HIV literature — work that sits squarely at the intersection of her research training and SunnyPharma’s subject matter.
In parallel, Ana invested heavily in scientific communication and visual storytelling: two Scientific Illustration courses, a post-graduate program in Biostatistics in Health Sciences, and continuous self-training in data visualization and design. She has been a member of the European Medical Writers Association (EMWA) since 2018, holds the EMWA EPDP Foundation Certificate, and has served as an EMWA workshop leader.
Today, Ana is Head of Medical Writing at P95 Epidemiology and Pharmacovigilance, where she leads the preparation of clinical study reports, systematic reviews, regulatory manuscripts, conference posters, and slide presentations. She brings that same regulatory-grade discipline to her work as a medical writer for SunnyPharma.
What Ana Contributes to SunnyPharma
Selected Peer-Reviewed Research
Ana has authored or co-authored more than 25 papers in international peer-reviewed journals, alongside professional articles in medical-writing publications. Selected works:
Definition of Immunological Non-Response to Antiretroviral Therapy: A Systematic Review — Rb-Silva R, Goios A, Kelly C, et al. JAIDS, 2019;82(5):452–461. View publication ↗
Reconstructing the Indian Origin and Dispersal of the European Roma: A Maternal Genetic Perspective — Mendizabal I, … Goios A, et al. PLOS ONE, 2011;6(1). View publication ↗
mtDNA Phylogeny and Evolution of Laboratory Mouse Strains — Goios A, et al. Genome Research, 2007. View publication ↗
High-Resolution mtDNA Evidence for the Late-Glacial Resettlement of Europe — Pereira L, … Goios A, et al. Genome Research, 2005. View publication ↗
1000 Words in 1 Picture: Combining Art and Science in Medical Illustrations — Medical Writing (EMWA), 2019;28(1). Professional article.
Writing Standards & Editorial Transparency
All content authored by Ana Goios for SunnyPharma is developed in accordance with ICMJE (International Committee of Medical Journal Editors) recommendations, GPP (Good Publication Practice) guidelines, and current evidence-based clinical standards. Ana applies the same scientific rigor she brings to regulatory medical writing at P95, ensuring every article and guide is factually accurate, appropriately referenced, and suitable for a patient-facing audience.
Credentials & Background
PhD in Genetics — Faculty of Sciences, University of Porto. Dissertation on mitochondrial genome dynamics and the normal/pathogenic boundary.
BSc in Biology — Faculty of Sciences, University of Porto.
PgDip Biostatistics in Health Sciences + EMWA EPDP Foundation Certificate.
Head of Medical Writing, P95 Epidemiology and Pharmacovigilance — leads clinical study reports, systematic reviews, and regulatory manuscripts.
EMWA member since 2018; workshop leader. Based in Braga, Portugal. Languages: Portuguese, English, Spanish. LinkedIn ↗
Areas of Expertise
Why Ana Writes for SunnyPharma
Ana’s day job at P95 is regulatory writing for clinical trials and pharmacovigilance — work where every word is reviewed by ethics committees, regulators, and biostatisticians before it reaches anyone. She brings that same standard to SunnyPharma’s patient-facing content, but with one difference: the readers are the people the trials were trying to help. The bridge between the regulatory document and the person trying to afford their medication is exactly the bridge Ana spent her career learning to build.